Q4 2024 Aker Biomarine ASA Earnings Call Transcript
Key Points
- Aker BioMarine ASA (FRA:1PG) completed a significant transaction in the feed ingredients sector, resulting in a net gain of $214 million.
- The company paid out an extraordinary dividend of $373 million, equivalent to NOK45 per share.
- EBITDA increased by 10% year-over-year, driven by emerging business nearing break-even.
- Human health ingredients segment showed continued growth with an 8% increase year-over-year.
- Emerging business grew by 14%, with strong performance on Amazon and expansion into Japan and China.
- Overall revenue for the third quarter was down 7% year-over-year, primarily due to eliminations between segments.
- Consumer health products segment saw a 5% decrease year-over-year, attributed to strong performance in the previous year.
- There was a decrease in average price for crude oil, driven by customer and product mix.
- Houston production was lower than planned due to weather-related shutdowns, impacting volumes and gross margin.
- The company is facing challenges with inventory normalization in the consumer health products segment.
Good morning, and welcome to the presentation of the third quarter results for Aker BioMarine, where myself, Matts Johansen, and CFO Katrine Klaveness will take you through the highlights and the financial results for the quarter.
I am traveling today, so, we will have no video, just the slides and the voice. And for the same reason, we will not have a Q&A session at the end like we usually have. But you can reach out to [email protected]. If you have, questions or reach out to Katrine or myself directly, and we will try to answer your questions. You can also contact one of the brokers in D&B that will host a road show on Monday where we also will have a group call where we will present and also, they have a live Q&A session, at the end.
So, starting with the highlights for the third quarter 2024, the key milestone for the quarter is the closure of the transaction of feed ingredients, ended up at a total value of $624 million after we had adjusted for working capital and inventory. And that resulted in a net
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
